Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04765098
Title Tamoxifen Versus Lomustine After First Recurrence in GBM Patients
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AHS Cancer Control Alberta
Indications

glioblastoma

Therapies

Tamoxifen

Lomustine

Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.